rethinkTHC Search
Menu
Study breakdown

Combining a Cannabinoid with MDMA Reverses Memory Impairment in Rats Through a Specific Brain Mechanism

Animal StudyPreliminary evidence
The takeaway

In rats, MDMA (ecstasy) reversed the memory impairment caused by a synthetic cannabinoid through a mechanism involving NMDA glutamate receptors in the hippocampus.

Read this if you follow neuroscience research on how cannabis interacts with other substances at the brain level.

MDMA reversed cannabinoid-induced memory impairment via NMDA receptors

What the researchers found

Both cannabinoids and MDMA (ecstasy) can impair memory individually, but this study found something unexpected: when given together, MDMA actually reversed the memory problems caused by a synthetic cannabinoid.

The researchers injected the synthetic cannabinoid ACPA directly into the hippocampus of rats, which impaired their ability to remember a passive avoidance task. When MDMA was also injected into the same brain region, it rescued this memory deficit at higher doses.

This reversal effect depended on NMDA receptors, which are critical for memory formation. Blocking NMDA receptors with the drug D-AP5 prevented MDMA from rescuing the cannabinoid-induced memory impairment. The authors suggest this interaction may help explain why some people combine cannabis and ecstasy.

Why it matters

This study provides insight into the brain mechanisms underlying polydrug use involving cannabis and MDMA. Understanding how these substances interact at the neural level could inform both harm reduction strategies and the development of treatments for cognitive effects of substance use.

The numbers in context

ACPA at doses of 0.5-4 ng/rat impaired memory retrieval. MDMA at 0.5-1 ug/rat dose-dependently impaired memory alone but reversed ACPA-induced impairment at higher doses. D-AP5 at 1-2 ug/rat blocked MDMA's reversal effect.

How the study worked

Adult male Wistar rats received direct microinjections into the CA1 region of the hippocampus through surgically implanted cannulas. Memory was tested using a step-through passive avoidance task. The NMDA receptor antagonist D-AP5 was used to test the role of glutamate signaling in the interaction.

What this study cannot tell us

Direct brain injection does not reflect how people actually use these drugs. The synthetic cannabinoid ACPA may have different effects than THC. Rat memory tasks have limited applicability to human cognitive experiences. Doses and routes of administration are not clinically relevant.

How to read the evidence

Controlled animal study with clear mechanistic findings, but uses direct brain injection and synthetic cannabinoids with limited clinical relevance.

When this study was published

Published in 2016. Research on cannabinoid-MDMA interactions remains an active area of preclinical investigation.

The bigger picture

Polydrug use involving cannabis and MDMA is common among young adults. Understanding the neurochemical interactions may explain user behavior and help develop interventions. The NMDA receptor finding also adds to our understanding of how cannabinoids affect memory through the glutamate system.

Questions still open

  • Does this interaction occur with THC rather than synthetic cannabinoids? Would systemically administered drugs show the same pattern? Does this finding have any relevance to the common recreational combination of cannabis and MDMA?

Common questions

Do cannabis and MDMA interact in the brain?
Yes. In this rat study, MDMA reversed the memory impairment caused by a cannabinoid in the hippocampus, and this interaction depended on NMDA glutamate receptors.
Does this mean combining cannabis and MDMA is safe?
No. This was a highly controlled animal study using direct brain injections of specific compounds. It reveals a neural mechanism but cannot be translated into safety conclusions about recreational polydrug use.

Read the original research

Dorsal hippocampal NMDA receptors mediate the interactive effects of arachidonylcyclopropylamide and MDMA/ecstasy on memory retrieval in rats.

Progress in neuro-psychopharmacology & biological psychiatry, 66, 41-47

Citation

Ghaderi, Marzieh; Rezayof, Ameneh; Vousooghi, Nasim; Zarrindast, Mohammad-Reza. (2016). Dorsal hippocampal NMDA receptors mediate the interactive effects of arachidonylcyclopropylamide and MDMA/ecstasy on memory retrieval in rats.. Progress in neuro-psychopharmacology & biological psychiatry, 66, 41-47. https://doi.org/10.1016/j.pnpbp.2015.11.008

Explore the wider topic